Lidocaine
Back to searchMolecule Structure
Scientific Name
Lidocaine
Description of the Drug
Lidocaine is a local anesthetic used in a wide variety of superficial and invasive procedures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00281
http://www.drugbank.ca/drugs/DB00281
Brand Name(s)
Alphacaine, Anestacon, Dentipatch, Lidocaine, Lidoderm, Lignocaine Hcl, Lignostab, Lmx 4, Oraqix, Vagisil, Xylocaine, Xylodase, Xylotox, Ztlido
Company Owner(s)
Vitruvias Therapeutics Llc, Watson Laboratories Inc, Rhodes Pharmaceuticals Lp, Actavis Laboratories Ut Inc, Amphastar Pharmaceuticals Inc, Fresenius Kabi Usa Llc, Scilex Pharmaceuticals Inc, Tolmar Inc, Quagen Pharmaceuticals Llc, Noven Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL15689 | SCHEMBL17967359 | ||||||||
| PharmGKB | PA450226 | |||||||||
| Human Metabolome Database | HMDB0014426 | |||||||||
| DrugBank | DB00281 | |||||||||
| PubChem: Thomson Pharma | 15196283 | |||||||||
| PubChem | 3676 | |||||||||
| Mcule | MCULE-9294700940 | |||||||||
| LINCS | LSM-3165 | |||||||||
| Nikkaji | J5.631F | |||||||||
| PDBe | LQZ | |||||||||
| BindingDB | 50017662 | |||||||||
| EPA CompTox Dashboard | DTXSID1045166 | |||||||||
| DrugCentral | 1579 | |||||||||
| Brenda | 146897 | 229618 | 100862 | 9617 | 229619 | |||||
| ChemicalBook | CB3396663 | CB9128024 | ||||||||
| Guide to Pharmacology | 2623 | |||||||||
| rxnorm | LIDOCAINE | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | ORAQIX | SOLARCAINE | LIDODERM | GLYDO | ZINGO | AKTEN | ZTLIDO |
| KEGG Ligand | C07073 | |||||||||
| ChEBI | 6456 | |||||||||
| ZINC | ZINC000000020237 |
